324 related articles for article (PubMed ID: 35731648)
21. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
22. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
23. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
24. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of simultaneous integrated boost and sequential boost radiotherapy in node-positive cervical cancer: dosimetric and radiobiological considerations.
Mishra R; Singh S; Patel G; Mandal A; Mishra H; Pandey A; Bahadur B; Singh PK; Sachan S; Tewari M
Radiat Environ Biophys; 2024 May; 63(2):297-306. PubMed ID: 38722389
[TBL] [Abstract][Full Text] [Related]
26. Evaluating different radiotherapy treatment plans, in terms of critical organ scoring index, conformity index, tumor control probability, and normal tissue complication probability calculations in early glottic larynx carcinoma.
Inal A; Duman E; Ozkan EE
J Cancer Res Ther; 2020; 16(3):485-493. PubMed ID: 32719255
[TBL] [Abstract][Full Text] [Related]
27. Normal lung sparing Tomotherapy technique in stage III lung cancer.
Hong CS; Ju SG; Ahn YC; Yoo GS; Noh JM; Oh D; Chung K; Pyo H; Jo K
Radiat Oncol; 2017 Nov; 12(1):167. PubMed ID: 29110732
[TBL] [Abstract][Full Text] [Related]
28. Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC.
Roy S; Badragan I; Ahmed SN; Sia M; Singh J; Bahl G
Pract Radiat Oncol; 2018; 8(5):e355-e363. PubMed ID: 29703705
[TBL] [Abstract][Full Text] [Related]
29. Robust Optimization of SBRT Planning for Patients With Early Stage Non-Small Cell Lung Cancer.
Shang H; Pu Y; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820916505. PubMed ID: 32314663
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.
Li XA; Wang JZ; Jursinic PA; Lawton CA; Wang D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1251-7. PubMed ID: 15752907
[TBL] [Abstract][Full Text] [Related]
31. Predicted Inferior Outcomes for Lung SBRT With Treatment Planning Systems That Fail Independent Phantom-Based Audits.
Greer MD; Koger B; Glenn M; Kang J; Rengan R; Zeng J; Ford E
Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1301-1308. PubMed ID: 36535431
[TBL] [Abstract][Full Text] [Related]
32. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
33. Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
Guckenberger M; Kavanagh A; Partridge M
Strahlenther Onkol; 2012 Oct; 188(10):894-900. PubMed ID: 22933031
[TBL] [Abstract][Full Text] [Related]
34. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
35. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients.
Fogliata A; Bolsi A; Cozzi L; Bernier J
Radiother Oncol; 2003 Dec; 69(3):267-75. PubMed ID: 14644486
[TBL] [Abstract][Full Text] [Related]
36. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
37. Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer.
Bai X; Shan G; Chen M; Wang B
Biomed Eng Online; 2019 Oct; 18(1):101. PubMed ID: 31619263
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
39. Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy.
Huang BT; Lu JY; Lin PX; Chen JZ; Li DR; Chen CZ
Sci Rep; 2015 Dec; 5():18010. PubMed ID: 26657569
[TBL] [Abstract][Full Text] [Related]
40. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
